![FOXO - FOXO Technologies Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=FOXO&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 2.36M | EPS (ttm) | -6.48 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 9.08 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 92.65% |
Dividend | - | Sales Q/Q | -38.46% |
Insider Own | 25.02% | Inst Own | 3.32% |
Insider Trans | -60.92% | Inst Trans | -77.29% |
Short Float | 0.78% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 1.96M | 52W Range | 0.22 - 3.28 |
|
|
|
FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment refers to the research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded in 2020 and is headquartered in Minneapolis, MN. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
WARD MARTIN CHRISTOPHER | Interim CFO | Jul 22 '24 | Sale | 0.25 | 1,300,000 | 325,000 | 0 | Jul 24 04:00 PM | WHITE MARK BRIAN | Interim CEO | Jul 22 '24 | Sale | 0.25 | 1,300,000 | 325,000 | 0 | Jul 24 04:00 PM | Kr8 ai Inc. | 10% Owner | Jul 22 '24 | Sale | 0.25 | 1,300,000 | 325,000 | 0 | Jul 24 04:00 PM | WHITE MARK BRIAN | Interim CEO | Feb 06 '24 | Sale | 0.42 | 250,000 | 105,000 | 0 | Feb 07 03:07 PM | WARD MARTIN CHRISTOPHER | Interim CFO | Feb 06 '24 | Sale | 0.42 | 250,000 | 105,000 | 0 | Feb 07 03:07 PM |
|
|
![](gfx/nic2x2.gif) |
![NUWE - Nuwellis Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=NUWE&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 0.46M | EPS (ttm) | -290.46 |
P/E | - | EPS this Y | 91.75% |
Forward P/E | - | EPS next Y | 71.58% |
PEG | - | EPS past 5Y | 84.44% |
P/S | 0.05 | EPS next 5Y | - |
P/B | 0.53 | EPS Q/Q | 89.53% |
Dividend | - | Sales Q/Q | 1.70% |
Insider Own | 0.03% | Inst Own | 20.01% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 63.72% | Earnings | May 07/b |
Analyst Recom | 3.00 | Target Price | 52.50 |
Avg Volume | 277.07K | 52W Range | 2.28 - 98.35 |
|
|
|
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN. |
|
![](gfx/nic2x2.gif) |
![AIMD - Ainos Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=AIMD&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 5.19M | EPS (ttm) | -3.16 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -3.59% |
P/S | 57.64 | EPS next 5Y | - |
P/B | 0.18 | EPS Q/Q | 8.80% |
Dividend | - | Sales Q/Q | -57.84% |
Insider Own | 52.61% | Inst Own | 1.09% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 7.95% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 737.05K | 52W Range | 0.68 - 5.15 |
|
|
|
Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. Its medtech solutions include COVID-19 Antigen Rapid Test Kit, VOC POCT-Ainos Flora, VOC POCT-Ainos Pen, VOC POCT-CHS430, Very Low-Dose Oral Interferon Alpha, and Synthetic RNA. The company was founded on June 26, 1984 and is headquartered in San Diego, CA. |
|
| ![](gfx/nic2x2.gif) |
![APTO - Aptose Biosciences Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=APTO&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 10.29M | EPS (ttm) | -6.27 |
P/E | - | EPS this Y | 70.25% |
Forward P/E | - | EPS next Y | 47.67% |
PEG | - | EPS past 5Y | 10.18% |
P/S | - | EPS next 5Y | - |
P/B | 65.14 | EPS Q/Q | 66.88% |
Dividend | - | Sales Q/Q | - |
Insider Own | 17.07% | Inst Own | 5.63% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.54% | Earnings | May 14/a |
Analyst Recom | 1.00 | Target Price | 6.00 |
Avg Volume | 67.79K | 52W Range | 0.57 - 5.10 |
|
|
|
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Seizinger Bernd R. | Director | Sep 22 '23 | Buy | 3.14 | 17,000 | 53,380 | 17,000 | Sep 25 05:03 PM |
|
|
![](gfx/nic2x2.gif) |
![YGMZ - MingZhu Logistics Holdings Ltd - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=YGMZ&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 6.13M | EPS (ttm) | -0.09 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.07 | EPS next 5Y | - |
P/B | 0.80 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 38.62% | Inst Own | 0.10% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 9.97% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 285.73K | 52W Range | 1.27 - 7.54 |
|
|
|
MingZhu Logistics Holdings Ltd. is a transportation company, which engages in the provision of trucking and delivery services. It also operates a truckload fleet. It operates through the following segments: Trucking Services, Car-Hailing and Driver Management Services, Car Owner Services, and Liquor Distribution. The company was founded by Jin Long Yang in 2002 and is headquartered in Shenzhen, China. |
|
| ![](gfx/nic2x2.gif) |
![CRKN - Crown ElectroKinetics Corp - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=CRKN&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 8.28M | EPS (ttm) | -2915.61 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 32.53% |
P/S | 10.23 | EPS next 5Y | - |
P/B | 0.44 | EPS Q/Q | 97.27% |
Dividend | - | Sales Q/Q | 3000.00% |
Insider Own | 0.02% | Inst Own | 0.07% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 11.55% | Earnings | Apr 01/b |
Analyst Recom | 3.00 | Target Price | 13500.00 |
Avg Volume | 1.42M | 52W Range | 3.08 - 853.20 |
|
|
|
Crown ElectroKinetics Corp. engages in the commercialization of electro kinetic technology for use in the smart glass market. It develops and sells optical switching film that can be embedded between glass or applied to the surface of glass or other rigid substrates such as acrylic, to electronically control opacity. The company was founded by Douglas B. Croxall and Timothy Koch on April 20, 2015 and is headquartered in Corvallis, OR. |
|
![](gfx/nic2x2.gif) |
![TURN - 180 Degree Capital Corp - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=TURN&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 34.80M | EPS (ttm) | -1.37 |
P/E | - | EPS this Y | 68.50% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 632.86 | EPS next 5Y | 30.00% |
P/B | 0.70 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | -92.10% |
Insider Own | 8.90% | Inst Own | 24.50% |
Insider Trans | 11.03% | Inst Trans | 0.37% |
Short Float | 0.03% | Earnings | May 13/a |
Analyst Recom | - | Target Price | - |
Avg Volume | 12.03K | 52W Range | 3.53 - 4.97 |
|
|
|
180 Degree Capital Corp. is a publicly owned corporate pension plan sponsor. It primarily provides its services to pension and profit sharing plans. The firm is a large advisory firm which provides portfolio management for pooled investment vehicles, pension consulting services. It manages separate client focused equity and balanced funds. It invests in exchange-traded equity securities, non exchange-traded equity securities, cash and cash equivalents and assets of the adviser that are primarily receivables and prepaid expenses. The firm conducts in-house research to make investments. The firm was formerly known as Harris & Harris Group, Inc. 180 Degree Capital Corp. was founded in 1981 and is based in Montclair, New Jersey. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rendino Kevin | Chairman and CEO | Jun 28 '24 | Buy | 3.68 | 5,800 | 21,344 | 789,299 | Jul 01 09:17 AM | Wolfe Daniel B | President | Jun 28 '24 | Buy | 3.78 | 2,500 | 9,446 | 250,000 | Jul 01 09:20 AM | Rendino Kevin | Chairman and CEO | Jun 27 '24 | Buy | 3.70 | 10,000 | 36,993 | 783,499 | Jul 01 09:17 AM | Bigelow Robert E III | VP, Head of Fund Development | Jun 27 '24 | Buy | 3.66 | 1,325 | 4,850 | 121,005 | Jun 28 09:09 AM | Wolfe Daniel B | President | Jun 14 '24 | Buy | 3.69 | 1,500 | 5,542 | 247,500 | Jun 17 09:01 AM |
|
|
| ![](gfx/nic2x2.gif) |
![MSGM - Motorsport Games Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=MSGM&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 5.45M | EPS (ttm) | -3.54 |
P/E | - | EPS this Y | 79.84% |
Forward P/E | - | EPS next Y | -71.57% |
PEG | - | EPS past 5Y | -34.46% |
P/S | 0.66 | EPS next 5Y | - |
P/B | 2.65 | EPS Q/Q | 74.20% |
Dividend | - | Sales Q/Q | 75.15% |
Insider Own | 54.45% | Inst Own | 1.63% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 2.38% | Earnings | May 07/a |
Analyst Recom | 3.00 | Target Price | 5.00 |
Avg Volume | 192.89K | 52W Range | 2.00 - 8.71 |
|
|
|
Motorsport Games, Inc. engages in the business of developing and publishing racing games. It operates under the Gaming and Esports segments. The Gaming segment focuses on the development and publishing of interactive racing video games, entertainment content, and services. The Esports segment is involved in the organization and facilitation of esports tournaments, competitions, and events for licensed racing games, as well as on behalf of third-party video game racing series and other video game publishers. The company was founded on August 2, 2018 and is headquartered in Miami, FL. |
|
![](gfx/nic2x2.gif) |
![EAF - GrafTech International Ltd. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=EAF&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 206.56M | EPS (ttm) | -1.08 |
P/E | - | EPS this Y | 58.10% |
Forward P/E | - | EPS next Y | 48.15% |
PEG | - | EPS past 5Y | - |
P/S | 0.33 | EPS next 5Y | -5.87% |
P/B | 5.49 | EPS Q/Q | -317.77% |
Dividend | - | Sales Q/Q | -1.60% |
Insider Own | 34.33% | Inst Own | 73.32% |
Insider Trans | 4.90% | Inst Trans | 1.19% |
Short Float | 10.57% | Earnings | Jul 26/b |
Analyst Recom | 3.40 | Target Price | 1.60 |
Avg Volume | 3.35M | 52W Range | 0.81 - 5.32 |
|
|
|
GrafTech International Ltd. engages in the manufacture of graphite electrode products essential to the production of electric arc furnace steel and other ferrous and non-ferrous metals. The firm also produces a needle coke product which is a raw material in producing graphite electrodes. Its customers include steel producers and other ferrous and non-ferrous metal producers in Europe, the Middle East and Africa, the Americas and Asia-Pacific, which sell its products into the automotive, construction, appliance, machinery, equipment, and transportation industries. The company was founded in 1886 and is headquartered in Brooklyn Heights, OH. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Colonial House Capital Ltd | 10% Owner | May 17 '24 | Buy | 1.72 | 332,770 | 572,897 | 31,358,061 | May 20 05:54 PM | Colonial House Capital Ltd | 10% Owner | May 10 '24 | Buy | 1.74 | 500,000 | 870,250 | 31,025,291 | May 13 04:07 PM | Colonial House Capital Ltd | 10% Owner | May 09 '24 | Buy | 1.77 | 114,178 | 202,438 | 30,525,291 | May 10 04:43 PM | Colonial House Capital Ltd | 10% Owner | May 06 '24 | Buy | 1.81 | 163,250 | 295,434 | 30,411,113 | May 07 04:05 PM | Colonial House Capital Ltd | 10% Owner | May 03 '24 | Buy | 1.77 | 533,009 | 944,599 | 30,247,863 | May 06 04:09 PM |
|
|
![](gfx/nic2x2.gif) |
![DNMR - Danimer Scientific Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=DNMR&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 61.35M | EPS (ttm) | -1.43 |
P/E | - | EPS this Y | 41.70% |
Forward P/E | - | EPS next Y | 38.28% |
PEG | - | EPS past 5Y | -18.65% |
P/S | 1.36 | EPS next 5Y | - |
P/B | 0.23 | EPS Q/Q | 27.09% |
Dividend | - | Sales Q/Q | -14.27% |
Insider Own | 10.45% | Inst Own | 35.39% |
Insider Trans | 0.00% | Inst Trans | -1.24% |
Short Float | 19.41% | Earnings | May 07/a |
Analyst Recom | 2.50 | Target Price | 1.51 |
Avg Volume | 890.72K | 52W Range | 0.52 - 2.92 |
|
|
|
Danimer Scientific, Inc. operates as a next generation bioplastics company. It focuses on the development and production of biodegradable materials. The firm sells its products under the brand name Nodax. Its applications for biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles. The company was founded on January 13, 2014 and is headquartered in Bainbridge, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Hunt Gregory W. | Director | Jun 01 '24 | Option Exercise | 0.00 | 23,256 | 0 | 23,256 | Jun 04 05:00 PM | HENDRIX RICHARD J | Director | Jun 01 '24 | Option Exercise | 0.00 | 18,272 | 0 | 68,272 | Jun 04 05:00 PM | AMBOIAN JOHN P | Director | Jun 01 '24 | Option Exercise | 0.00 | 26,578 | 0 | 26,578 | Jun 04 05:00 PM | Noda Isao | Director | Jun 01 '24 | Option Exercise | 0.00 | 16,611 | 0 | 21,182 | Jun 04 05:00 PM | COHEN CYNTHIA R | Director | Jun 01 '24 | Option Exercise | 0.00 | 18,272 | 0 | 18,272 | Jun 04 05:00 PM |
|
|
|